The company is focused on developing Immunoglobulin M or IGMantibodies as potential treatments for various cancers, as well as autoimmune and other diseases. IGMantibodies should have ...
IGMS), a clinical-stage biotechnology company creating and developing engineered IgMantibodies, today announced that Fred Schwarzer, Chief Executive Officer, and Mary Beth Harler, M.D., Head ...
as well as IgM antibody capture ELISAs. Neutralization test is one tool used for serodiagnosis. This test is the most specific of serological tests, but it is laborious and expensive. POC-PUUMALA ...
Some results have been hidden because they may be inaccessible to you